Rosemont Pharmaceuticals
Tim Busby is the Chief Financial Officer at Rosemont Pharmaceuticals and also serves as NED & Chair of CHS at Calderdale and Huddersfield NHS Foundation Trust. Prior to these roles, he was the Chief Financial Officer at Young's Seafood, where he played a key role in increasing the group's profitability. Tim has held various finance leadership positions at Hallmark Cards, Orangina Schweppes Group, and Cadbury plc. With a background in general management and finance, Tim has consistently demonstrated a strong ability to optimize financial performance and implement strategic improvements within the organizations he works for.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.